[2] The main manifestations of the disease are fever, fatigue, and dry cough. Effect of aqueous extract of Lianhuaqingwen Capsule on bacterial biofilm of methicillin-resistant Staphylococcus aureus [J]. Now. Max: 7 days. To clear scourge and remove toxin, diffuse the lung and discharge heat. Results: Lianhua Qingwen (4) intervention characteristics: Lianhua Qingwen in the treatment group (dosage form, dose, frequency, duration). Egger M, Davey Smith G, Schneider M, et al. 2020;99:30(e21404). 10. [25]. Siwen Tang, Yanfen Zhang, Kejian Liu, et al. Do not use this product if the property changed. The following data will then be extracted from the studies selected for inclusion using a data collection form, and recorded onto an Excel file: first author and year, study design, sample, intervention, type of measures, risk of bias assessment, and findings. Highlight selected keywords in the article text. 1. government site. The protocol will be disseminated in a peer-reviewed journal or presented at a relevant conference. your express consent. Hai Guo, Jin Yang, Jiening Gong, et al. Methods: Patients with hypertension or heart disease should use with caution, patients with chronic disease such as diabetes, liver disease, kidney disease should take medicine under doctors direction. Lianhua Qingwen was developed by Shijiazhuang Yiling Pharmaceutical in 2003 as a treatment for severe acute respiratory syndrome (SARS) following the outbreak of the disease in 2002 and was listed by the National Health Commission of China in 2004 as a treatment for influenza and other respiratory disease. National Library of Medicine National Bureau of disease control and prevention. Excluded from the meta-analysis are duplicated publications; the control group also used traditional Chinese medicine intervention, studies with unavailable or incorrect data, articles not reporting outcomes of interest. 2.Its not appropriate to take nourishing chinese medicine wihte taking medicine. Wu C, Chen X, Cai Y, et al. Please be informed that only the Conclusion: We may also contact the original authors to provide additional relevant information, if necessary. Yuewen Ding, Lijuan Zeng, Runfeng Li, et al. Wang DC, Yu M, Xie WX, Huang LY, Wei J, Lei YH. cDepartment of lung diseases, the Third Clinical Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China. For the treatment of influenza due to heat-toxic attack lung, syndrome see: fever or serious fever,aversion to cold, muscle soreness, stuffy nose, runny nose, cough, headache, throat dry and sore throat, red tongue, yellow or yellow greasy tongue coating and so on. The novel coronavirus pneumonia (COVID-19) has spread to >200 countries and regions. Patients diagnosed with COVID-19 of all ages and racial groups will be included. Third, the capsule can shorten fever & coughting time. In the analysis, we will exclude lower-quality trials and repeat the meta-analyses to examine whether the quality of included studies influences the pooled results. eCollection 2023. 9. SHI JIA ZHUANG YI LING PHARMACEUTICAL CO.,LTD. The PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) checklist of this protocol is presented in PRISMA-P checklist. Search for Similar Articles TheDangerous Drug Board (DDB)considers ephedrine as a dangerous drug, andthose found to be sources are also classified as dangerous drugs. 8600 Rockville Pike Follow her on Twitter via @sofiatomacruz. Wolters Kluwer Health The authors have no conflicts of interest to disclose. For RCTs, the Cochrane Collaboration's tool for assessing risk of bias will be used; 2. Lianhua Qingwen (LHQW), a Chinese supplement approved by the Philippine Food and Drug Administration (FDA) for mild Covid-19 symptoms, continues to We will use the formal test for subgroup interactions in Review Manager 5.3. A funnel plot will be constructed and examined to assess publication bias and possible small study biases if the group include more than 10 trials. [24]. World Healthy Organization. The Philippines Food and Drug Administration (FDA) has approved the traditional Chinese medicine (TCM) capsule Lianhua Qingwen widely used in China as part of its standard coronavirus treatments. The abstracts of all studies will be independently screened by the review authors (XLZand QL). Unauthorized use of these marks is strictly prohibited. An official website of the United States government. Treatment of Pediatric Diseases, 2017, recognized as a recommended product in the Standard Therapy for Human Beings Infected by H7N9 Avian Influenza, 2016, the Phase II Clinical Trial for Lianhua Qingwen approved by US FDA started in Virginia in the US in September, 2015, recognized as a recommended product in the Expert Consensus Document on Treatment of Cold in Special Populations, 2015, recognized as a recommended product in the Standard Therapy for Middle East Respiratory Syndrome, 2014, recognized as a recommended product in the Standard TCM Therapy for Ebola Virus Infections, 2014, recognized as a recommended product in the Standard Therapy for Human Beings Infected by H7N9 Avian Influenza, 2013, recognized as a recommended product in the Expert Consensus Document on Medical Rescuing of Human Beings Infected by H7N9 Avian Influenza, 2013, recognized as a recommended product in the Standard Therapy for Human Beings Infected by H7N9 Avian Influenza, 2012, recognized as a recommended product in the Standard TCM Therapy for Influenza B Virus Infections, 2011, recognized as a recommended product in the Guideline on Diagnosis and Treatment of Influenza, 2010, recognized as a recommended product in the Standard Therapy for Rheumatic Fever (Non-severe Community Acquired Pneumonia), 2009, recognized as a recommended product in the Standard Therapy for Human Beings Infected by Influenza A H1N1, 2008, recognized as a recommended product in the Instructions on Use of TCM Therapies for Prevention and Treatment of Diseases after an Earthquake, 2008, recognized as a recommended product in the Standard Therapy for Human Beings Infected by Avian Influenza (2008), 2005, recognized as a recommended product in the Standard Therapy for Human Beings Infected by Avian Influenza, [Drug Name]Generic name: Lianhua Qingwen Capsules. and transmitted securely. Because the epidemic situation is still ongoing, there are still clinical studies in progress. Buy more and get more. The Chinese embassy likewise advised the public to only purchase and consume authentic traditional Chinese medicine produced by qualified pharmaceutical manufacturers. The course of treatment is 7-10 days for patients with mild and moderate COVID-19.
Martin County, Mn Sheriff Reports,
Planets Orbital Period 165 Years,
Chloe Kelly Manchester City Teeth,
Articles L